|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of P53-defective,oncogenic transformed cells and inhibits tumor growth in animals显示文摘 | Guan R Tapang P Leverson JD | 2005 | Cancer Res2005，65，7： | 1 |
| 2 | Pim-1 kinase and p100 cooperate to enhance c-Myb activity显示文摘 | Leverson JD Koskinen PJ Orrico FC | 1998 | Mol Cell1998，2，4： | 1 |
| 3 | Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins显示文摘 | Sun H Leverson JD Hunter T | 2007 | EMBO J2007，26，18： | 1 |
| 4 | New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response显示文摘 | Luo Y Leverson JD | 2005 | Expert Rev Anticancer Ther2005，5，2： | 1 |
| 5 | Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism显示文摘 | LEVERSON JD NESS SA | | 0，，： | 1 |
| 6 | ABT-199,a potent and selective BCL-2 inhibitor,achieves antitumor activity while sparing platelets显示文摘 | Souers AJ Leverson JD Boghaert ER | 2013 | Nat Med2013，19，2： | 1 |
| 7 | PIM-1 kinase and pl00 cooperate to enhance c-Myb activity显示文摘 | Leverson JD Koskinen PJ Orrico FC | 1998 | Mol Cell1998，2，4： | 1 |
| 8 | ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets显示文摘 | Souers AJ Leverson JD Boghaert ER | 2013 | Nat Med2013，19，2： | 1 |
| 9 | ABT-199,apotent and selective BCL-2inhibitor,achieves antitumor activity while sparing platelets显示文摘 | Souers AJ Leverson JD Boghaert ER | 2013 | Nat Med2013，19，： | 1 |
| 10 | ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets显示文摘 | Souers AJ Leverson JD Boqhaert ER | 2013 | Nat Med2013，19，2： | 1 |
| 11 | Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263(navitoclax)显示文摘 | LEVERSON JD ZHANG H CHEN J | 2015 | Cell death&disease2015，6，1： | 1 |
| 12 | ABT-199,a potent and selective BCL-2 inhibitor,achieves antitumor activity while sparing platelets显示文摘 | Souers AJ Leverson JD Boghaert ER | 2013 | Nat Med2013，19，2： | 1 |
| 13 | New opportunities in chemosensitization and radiosensitization:modulating the DNA-damage response显示文摘 | Luo Y Leverson JD | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员